Assessing endocrine resistance: monitoring circulating ESR1 mutations in Irosustat-treated ER positive breast cancer.

Page K, Martinson LJ, Hastings RK, Acheampong E, Wadsley MK, Allsopp RC, Luo JL, Coombes RC, Shaw JA, Palmieri C

DOI: 10.1007/s10549-025-07857-6
Published: 2025 Dec 9
Container: Breast cancer research and treatment
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s10549-025-07857-6,
  title = {Assessing endocrine resistance: monitoring circulating ESR1 mutations in Irosustat-treated ER positive breast cancer.},
  author = {Page K and Martinson LJ and Hastings RK and Acheampong E and Wadsley MK and Allsopp RC and Luo JL and Coombes RC and Shaw JA and Palmieri C},
  year = {2025},
  journal = {Breast cancer research and treatment},
  doi = {10.1007/s10549-025-07857-6},
  url = {https://doi.org/10.1007/s10549-025-07857-6}
}

RIS

TY  - JOUR
TI  - Assessing endocrine resistance: monitoring circulating ESR1 mutations in Irosustat-treated ER positive breast cancer.
AU  - Page K
AU  - Martinson LJ
AU  - Hastings RK
AU  - Acheampong E
AU  - Wadsley MK
AU  - Allsopp RC
AU  - Luo JL
AU  - Coombes RC
AU  - Shaw JA
AU  - Palmieri C
PY  - 2025
JO  - Breast cancer research and treatment
DO  - 10.1007/s10549-025-07857-6
UR  - https://doi.org/10.1007/s10549-025-07857-6
ER  -

APA

K, P., LJ, M., RK, H., E, A., MK, W., RC, A., JL, L., RC, C., JA, S., & C, P. (2025). Assessing endocrine resistance: monitoring circulating ESR1 mutations in Irosustat-treated ER positive breast cancer.. Breast cancer research and treatment. https://doi.org/10.1007/s10549-025-07857-6

Source records

pubmed · retrieved 2026-09-27T12:26:06.789Z